| CAS ID: | 55096-26-9 |
| Molecular Formula: | C21H25NO3 |
| Molecular Weight: | 339.4 g/mol |
| Monoisotopic Mass: | 339.1834 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ORF 11676 | NALMETRENE | JF-1 | NALMEFENE | SELINCRO | Revex | NALMEFENE HYDROCHLORIDE | REVEX |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C21H25NO3/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13/h4-5,13,16,19,23-24H,1-3,6-11H2/t16-,19+,20+,21-/m1/s1 | See All |
| InChI Key: | WJBLNOPPDWQMCH-MBPVOVBZSA-N | |
| Smiles: | Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=C)CC[C@@]36O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02824354 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Not yet recruiting |
| First Received | July 6, 2016 | Last Verified | August 6, 2018 |
| Sponsor | Centre Hospitalier Universitaire, Amiens | ||